Cycloartane-type triterpenoids from Combretum quadrangulare Kurz with PCSK9 secretion inhibitory activities
최영희
PHYTOCHEMISTRY, 202411
2
PHARMACOKINETIC FEASIBILITIES OF CO-AMORPHOUS DISPERSIONS OF MIRABEGRON IN RATS AND MICE
Choi Young Hee, Kim Seo-Yeon
DRUG METABOLISM AND PHARMACOKINETICS, 202404
3
Dihydrostilbenes and flavonoids from whole plants of Jacobaea vulgaris
최영희
PHYTOCHEMISTRY, 202404
4
PHARMACOKINETIC INTERACTION OF CAFFEINE AND THEOPHYLLINE IN MICE
Choi Young Hee, Yu Jeong-Eun
DRUG METABOLISM AND PHARMACOKINETICS, 202404
5
Stereochemical assignment of clerodane-type diterpenes from the fruits of Casearia grewiifolia and their ability to inhibit PCSK9 expression
최영희
PHYTOCHEMISTRY, 202312
6
No Interference of H9 Extract on Trastuzumab Pharmacokinetics in Their Combinations
최영희
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 202311
7
Improved Pharmacokinetic Feasibilities of Mirabegron-1,2-Ethanedisulfonic Acid, Mirabegron-1,5-Naphthalenedisulfonic Acid, and Mirabegron-L-Pyroglutamic Acid as Co-Amorphous Dispersions in Rats and Mice
최영희
PHARMACEUTICS, 202309
8
Evaluation of Pharmacokinetic Feasibility of Febuxostat/L-pyroglutamic Acid Cocrystals in Rats and Mice
최영희
PHARMACEUTICS, 202307
9
Pharmacokinetic Feasibility of Stability-Enhanced Solid-State (SESS) Tenofovir Disoproxil Free Base Crystal
최영희
PHARMACEUTICS, 202305
10
Change of metformin concentrations in the liver as a pharmacological target site of metformin after long-term combined treatment with ginseng berry extract